@bigal_com@BabakGhorb18348@TobiasAloha I think Merck could be a potential suitor, tbh I remain amazed that this CC with Kite was published one month later, right before data release, not implying anything but surprising for sure. I think control arm will start dying if they haven't already... This will go to P3
@BobChri59794625@scottm2032@GripRoom Well you don't know the rational behind it, might be BO looming with GMP facilities, although GRTS has it too. Maybe, BP wants to start coral study, maybe a deal is already signed 🤷♂️🤷♂️
@SheffStation Bodes very well, plus recent restructuration of the company, multiple phase 3 expected for different indications. Could be a revolution in cancer field!